Bile duct cancer, Biliary tree cancers, Gallbladder cancer, Secondary cancers
Open
Phase 3
This trial is looking at adding a drug called zanidatamab to for bile duct and gallbladder cancer.
It is for people whose cancer:
has spread into surrounding tissues and they can’t have surgery to remove it or it has spread elsewhere in the body
is
You pronounce zanidatamab as zan-i-dat-a-mab.
Recruitment start: 19 July 2024
Recruitment end: 1 December 2028
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr James J Harding
Jazz Pharmaceuticals
Last reviewed: 20 Jan 2026
CRUK internal database number: 20041